Navigation Links
Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
Date:11/7/2013

013 and December 31, 2012

851,468923,362Prepaid income taxes

7,3817,381Prepaid expenses and other current assets

61,01783,435Total current assets

1,187,4601,231,904PROPERTY AND EQUIPMENT, NET

58,85530,282Deposits

-6,472Intangible assets, net

48,65685,130TOTAL ASSETS

$1,294,971$1,353,788LIABILITIES AND STOCKHOLDERS' DEFICITCURRENT LIABILITIESAccounts payable

$1,201,703$1,199,846Accrued employee compensation

165,515119,338Accrued professional fees and other

570,595267,936Deferred revenue

18,09946,466Promissory note

75,00075,000Dividend liability

-60,000Related party debt

27,73998,675Convertible debt, net of debt discount of $334,021 and $0, respectively

358,514863,004Conversion option liability

281,127-Warrant derivative liability

170,137160,812Total current liabilities

2,868,4292,891,077LONG TERM LIABILITIESConvertible debt – long term

100,000-Deferred revenue

-2,487TOTAL LIABILITIES

2,968,4292,893,564COMMITMENTS AND CONTINGENCIESSTOCKHOLDERS' DEFICITSeries D convertible preferred stock, $.01 par value; 850 shares authorized; 300 shares issued and outstanding on September 30, 2013 and on December 31, 2012

33Series G convertible preferred stock, $.01 par value; 240,000 shares authorized; 145,320 shares issued and outstanding on September 30, 2013 and on December 31, 2012

1,4531,453Series H convertible preferred stock, $.01 par value; 10,000 shares authorized; 10,000 shares and 0 shares issued and outstanding on September 30, 2013 and on December 31, 2012, respectively

100-Series J convertible preferred stock, $.01 par value; 6,250 shares authorized; 5,087.5 shares and 0 shares issued and outstanding on September 30, 2013 and on December 31, 2012

51-Common stock, $.01 par value; 50,000,000 shares authorized; 11,949,267 and 12,149,267
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update
2. Blood Pressure Monitoring Testing Market is Expected to Reach USD 3.7 Billion Globally in 2019: Transparency Market Research
3. Hazardous, High-Pressure and Explosive Conditions Are No Match for Swiss Jewel Sapphire Windows
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
5. China Medical Flat Panel Detector Market & Pressure Injector 2013 Research Reports Now Available at ReportsnReports.com
6. Using pressure to swell pores, not crush them
7. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
8. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
9. High pressure gold nanocrystal structure revealed
10. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
11. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 Lawrence Livermore ... to Thomson Reuters list of " The World's Most ... part of the 3,000 researchers who were identified by ... recognize those who published the highest-impact work (2002-2012 and ... papers on combustion modeling . , "This recognition ...
(Date:7/24/2014)... Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the publication ... 3 study of Zerenex (ferric citrate), the Company,s investigational ... hyperphosphatemia in patients with end-stage renal disease (ESRD) on ... with FErric CiTrate in EsrD) was published online today ... Nephrology ( JASN ). , This ...
(Date:7/24/2014)... , July 24, 2014  ECC West Africa, ... Colorado with University College Hospital (UCH) Ibadan ... development project to finance, design, construct, and operate and ... Nigeria . Under the first of the ... scoping documents and funding applications. UCH Ibadan intends to ...
(Date:7/24/2014)... most natural and synthetic processes prefer to settle ... or energyit is within the realm of non-equilibrium ... constant changes in energy and phases, such as ... conditions allow humans to regulate their body temperature, ... with seismic activity. , But even though ...
Breaking Biology Technology:Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2New approach to form non-equilibrium structures 2
... LAKE ZURICH, Ill., July 14 Fenwal Inc., a global ... and availability, announced today it has signed a five-year exclusive ... distribute Verax,s unique PanGenera(R) Detection (PGD) technology, a rapid diagnostic ... , , ...
... HORSHOLM, Denmark, July 14 The Board of Directors of,Santaris Pharma has ... - The loss after tax realised in the 2nd quarter of ... DKK (4,0m EUR) in the 2nd, quarter of 2008., ... DKK (23,6m EUR)., - In Q2 ...
... Austria, July 14 Elan Corporation, plc (NYSE: ELN ... week at the Alzheimer Association 2009 International Conference on Alzheimer,s Disease ... growing burden of care and costs associated with Alzheimer,s disease (AD) ... the impact of AD, which, as the population ages, will place ...
Cached Biology Technology:Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test 2Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test 3Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 2Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 3Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 4Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 5Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 6Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 7Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 8Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 9Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 2Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 3Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 4Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 5Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 6Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 7
(Date:7/24/2014)... MADISON A multi-institutional team of researchers has developed ... tract. This safe, noninvasive method for assessing the function ... could lead to better diagnosis and treatment of gut ... bacterial overgrowth, irritable bowel syndrome and inflammatory bowel disease ... serious side effects in patients with diseases such as ...
(Date:7/24/2014)... similar counterparts in humans, affect the connections between nerve ... the hippocampus, an area of the brain that plays ... of memories. The results of the study have been ... function depends on the active communication between nerve cells, ... together into a dense network where they constantly relay ...
(Date:7/24/2014)... in the United States, wildland managers often utilize the ... trees (ladder fuels). These cuttings and other post-logging ... danger in order to dispose of the material. To ... often cover all or part of the debris pile ... plastic, in order to keep water out. A recent ...
Breaking Biology News(10 mins):New imaging agent provides better picture of the gut 2A protein couple controls flow of information into the brain's memory center 2A protein couple controls flow of information into the brain's memory center 3A protein couple controls flow of information into the brain's memory center 4Study gives new perspective on agricultural plastic, debris burning, and air quality 2
... The deposition of amyloid beta in the brain of ... into both its cause and treatment. While there ... contributes to the disease or is a consequence of the ... meaning that something else is promoting the process. Other ...
... Have you ever been disappointed by a cantaloupe from the ... researchers from the University of California, Davis might have found ... the past. The method will be published on March 30 ... ). "We are involved in a project geared towards ...
... if there is a link between living near nuclear power ... of cancer, but challenges and limitations exist, says a new ... the National Academy of Sciences and National Academy of Engineering. ... first to evaluate the feasibility of a full-scale study, although ...
Cached Biology News:The electronic nose knows when your cantaloupe is ripe 2Report presents designs for study of cancer risks near US nuclear facilities 2Report presents designs for study of cancer risks near US nuclear facilities 3
...
...
... White solid. PROTECT FROM LIGHT. ... sulfanamido-benzbromarone compound that acts as a ... of PTP1B (IC 50 = ... PTP1B 403 and PTP1B 298 ...
...
Biology Products: